1998
DOI: 10.1016/s0167-4838(98)00224-6
|View full text |Cite
|
Sign up to set email alerts
|

Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
98
1

Year Published

2001
2001
2015
2015

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 147 publications
(101 citation statements)
references
References 31 publications
2
98
1
Order By: Relevance
“…Most of these activities reside in the N-domain of lactoferrin [31]. This domain is also termed as antimicrobial domain due to release of lactoferricin, a more potent antimicrobial peptide, by pepsin digestion [6,32] and lactoferrampin, a second stretch of N1 domains reported as another novel antmicrobial peptide [33]. Therefore, bifidobacteria may make protection against antimicrobial activity of lactoferrin by binding with this domain.…”
Section: Resultsmentioning
confidence: 99%
“…Most of these activities reside in the N-domain of lactoferrin [31]. This domain is also termed as antimicrobial domain due to release of lactoferricin, a more potent antimicrobial peptide, by pepsin digestion [6,32] and lactoferrampin, a second stretch of N1 domains reported as another novel antmicrobial peptide [33]. Therefore, bifidobacteria may make protection against antimicrobial activity of lactoferrin by binding with this domain.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, it has been demonstrated that lactoferrin, a protein that binds iron in milk, has antimicrobial activity after cleavage (73). However, why an mRNA encoding the antimicrobial peptide hepcidin is induced during iron overload remains an open question.…”
Section: Discussionmentioning
confidence: 99%
“…37,38 Although a recent study failed to demonstrate the presence of dietary bovine lactoferrin or functional fragments of bovine lactoferrin such as LfcinB in the portal blood of rats, 39 the systemic antiangiogenic activity of ingested bovine lactoferrin in both rats and mice 35,36 suggests that transfer of LfcinB to circulating blood is likely to in fact take place. However, it is important to realize that a systemic distribution of LfcinB at the concentration (200 g/ml) that showed antiangiogenic activity in our in vivo and in vitro assays cannot be attained by the normal consumption of dairy products containing bovine lactoferrin as a source of LfcinB because cow's milk, for example, contains less than 100 mg/L lactoferrin.…”
Section: Discussionmentioning
confidence: 99%